Synthesis and biological evaluation of novel imidazolone derivatives as potential COX-2 inhibitors

Archives of Pharmacal Research

Volumn 31, Issue 5, 2008, Pages 562-568

  Hassanein, Hassanein H ^a   Khalifa, Maha M ^b   El Samaloty, Ola N ^b   El Rahim, Mohamed Abd ^a   Taha, Ragia A ^b   Ismail, Magda M F ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Al Azhar University   (Egypt)

Author keywords

Anti inflammatory; COX 2 inhibition; Imidazolones; Oxazolones

Indexed keywords

CARRAGEENAN; CYCLOOXYGENASE 2 INHIBITOR; IMIDAZOLE DERIVATIVE; PROSTAGLANDIN E2;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; EDEMA; FEMALE; HUMAN; IN VITRO STUDY; MALE; RAT; SYNTHESIS;

ANIMALS; CARRAGEENAN; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; EDEMA; FEMALE; HUMANS; IMIDAZOLES; MALE; RATS;

EID: 43749091971     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1193-6     Document Type: Article

References (22)

1. Black, W.C., Selective cyclooxygenase-2 inhibitors. Ann. Rep. Med. Chem., 39, 125-138 (2004).
2. th ed. Amsterdam: Elsevier (1990).
3. Chi, Y. S., Cheon, B. S., and Kim, H. P., Effect of wogonin, a plant flavone from scutellaria radix on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharides treated RAW 264.7 cell. Biochem. Pharmacol., 61, 1195 (2001).
4. Erlenmeyer, E., Azlactone and amino acid synthesis. Ann., 275,1(1893) Ber., 203,33 (1990).
5. th ed, Lea and Febige Philadelphia London pp. 535 (1995).
6. th ed, p 884 (1978).
7. Hassanein, H. H. and Abdel Gawad, N., New anthranilates of potential analgesic and anti-inflammatory activities. Zagazig J. Pharm. Sc., 4,1, 168 (1995).
8. Ismail, I. M., Islam, A. M., El-sherief, A. M., and Harb, A. A., Reaction of some 2-aryl-4-arylidene-1,3-oxazolin-5-ones. Egypt J. chem., 26,3, 221 (1983).
9. Kalgutkar, A., Selective cyclooxy-genase-2 inhibitors as non-ulcerogenic anti-inflammatory agents. Exp. Opin. Ther. Pat., 9, 831 (1999).
10. Khalifa, M. M., Abou El Ella, D. A., Ismail, M. M. F., Abd El Baky, N. A., and Ammar, Y. A., Synthesis, molecular modeling and in vivo study of novel diarylimidazolones as potential COX-2 inhibitors. Bull. Fac. Pharm. Cairo Univ., 70, 173 (2007).
11. Khanna, I. K., Yu-Y., Renee, M., Koszyk, F. J., and Collins, P. W., Selective cyclooxygenase-2 inhibitor heteroaryl modified 1,2-diarylimidazoles are potent orally active anti-inflammatory agents. J. Med. Chem., 43, 3168 (2000).
12. Lambardino, G., Nonsteroidal Anti-inflammatory Drugs. Wiley Interscience; John Wiley and sons: New York (1985).
13. Leblanc, Y., Black, W. C., Chan, C-C., Charleson, S., Delmore, D., Mancini, J. A., Riendeau, D., Tagari, P., Vickers, P. J., and Prasit, P., Synthesis and biological evaluation of both enantiomers of L-761,000 as inhibitors of cyclooxygenase 1 and 2. Bioorg. Med. chem. Lett., 6, 731 (1996).
14. Needleman, P. and Isakson, P., The discovery and function of COX-2. J. Rhematol., 24(Suppl 49),6-8 (1997).
15. Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., Rogers, R. S., and Rogier, D. J., Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors. J. Med. chem., 40, 1347 (1997).
16. Prasit, P., Wang, Z., Brideau, C., Chan, C-C, Charleson, S., Cromlish, W., Ethier, D., and Evans, J. F., The discovery of rofecoxib, an orally active cyclooxygenase-2 inhibitor. Bioorg. Med. Chem. Lett., 9, 1773-1778 (1999).
17. Puig, C., Crespo, I. M., Godessart, N., Feixes, J., Jimenez, J. M. et al., Synthesis and biological evaluation of 3,4-diaryloxazolones. A new class of orally active cyclooxygenase-2 inhibitor. J. Med. Chem., 43, No 2, 214-223 (2000).
18. Reitz, D. B. and Isakson, P. C., Cyclooxygenase-2 inhibitors. Current. Pharm. Design., 1, 211 (1995).
19. th Edition, Iouis State University Press, Ames, Iowa, U.S.A. (1971).
20. Tuyen, T. N., Sin, K.-S., Kim, H. P., and Park, H., Synthesis and anti-inflammatory activity of 1,5-diarylimidazoles. Arch. Pharm. Res., 28,9, 1013-1018 (2005).
21. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., and Vane, J. R., Non steroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gasteroin-testinal toxicity, a full in vitro analysis. Proc. Natl. Acad. Sci., U.S.A., 96, 7563-7568 (1999).
22. Winter, C. A., Risley, E. A., and Nuss, G. W., Carrageenin induced edema in hind paw. Proc. Soc. Exp. Biol. Med., 111, 544 (1962).